Novel Synthetic Nucleic Acid Technology Development (R43/R44)( Clinical Trial not allowed)

0
237

Funding Opportunity ID: 325615
Opportunity Number: RFA-HG-20-016
Opportunity Title: Novel Synthetic Nucleic Acid Technology Development (R43/R44)( Clinical Trial not allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
CFDA Number(s): 93.350
Eligible Applicants: Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Agency Code: HHS-NIH11
Agency Name: Department of Health and Human Services
National Institutes of Health
Posted Date: Mar 19, 2020
Close Date: Jun 24, 2022
Last Updated Date: Mar 19, 2020
Award Ceiling: $0
Award Floor: $0
Estimated Total Program Funding:
Expected Number of Awards:
Description: This Funding Opportunity Announcement (FOA) solicits R43/R44 grant applications from small businesses to develop novel technologies that will enable substantive (no less than one order of magnitude) improvement in synthetic nucleic acids. The goal is to improve the quality, capabilities and efficiency of nucleic acid synthesis and synthetic constructs at reasonable and decreased costs. Large progress in this area has the potential to catalyze scientific advances relevant to the mission of NIH, NHGRI and the field of genomics.
Version: 1





Visit the Official Webpage For More Details on Novel Synthetic Nucleic Acid Technology Development (R43/R44)( Clinical Trial not allowed)